TESTBANK d4
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
d4 d4 d4 d4 d4 d4 d4
Author:Teri Moser Woo and WendyL. Wright
d4 d4 d4 d4 d4 d4 d4
, TABLE OF CONTENT d4 d4
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber............................................................................ 4
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................... 5
d4 d4 d4 d4 d4 d4 d4
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
d4 d4 d4 d4
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
d4 d4 d4 d4 d4 d4 d4
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
d4 d4 d4 d4
Chapter 6. An Introduction to Pharmacogenomics................................................................................................. 19
d4 d4 d4 d4 d4
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
d4 d4 d4 d4
Chapter 8. Herbal Therapies.................................................................................................................................. 28
d4 d4 d4
Chapter 9. Cannabis.............................................................................................................................................. 31
d4 d4
Chapter 10. Pharmacoeconomics .......................................................................................................................... 35
d4 d4
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
d4 d4 d4 d4 d4 d4 d4
Chapter 12. Drugs Affecting the Central Nervous System...................................................................................... 45
d4 d4 d4 d4 d4 d4 d4
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems...................................................................... 53
d4 d4 d4 d4 d4 d4 d4 d4
Chapter 14. Drugs Affecting the Respiratory System............................................................................................. 61
d4 d4 d4 d4 d4 d4
Chapter 15. Drugs Affecting the Hematological System ........................................................................................ 65
d4 d4 d4 d4 d4 d4
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
d4 d4 d4 d4 d4 d4 d4
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
d4 d4 d4 d4 d4 d4
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 21. Drugs Affecting the Reproductive System .......................................................................................... 86
d4 d4 d4 d4 d4 d4
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
d4 d4 d4 d4 d4 d4 d4
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
d4 d4 d4 d4 d4 d4
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................... 101
d4 d4 d4 d4 d4 d4 d4
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.............................................................. 105
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................... 108
d4 d4 d4 d4 d4 d4 d4
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 28. Anemia ............................................................................................................................................ 113
d4 d4
Chapter 29. Anxiety and Depression ................................................................................................................... 116
d4 d4 d4 d4
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
d4 d4 d4 d4
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
d4 d4 d4 d4
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
d4 d4 d4 d4 d4
Chapter 33. Contraception .................................................................................................................................. 127
d4 d4
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
d4 d4 d4 d4 d4
Chapter 35. Dermatological Conditions .............................................................................................................. 134
d4 d4 d4
Chapter 36. Diabetes Management ..................................................................................................................... 138
d4 d4 d4
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
d4 d4 d4 d4 d4 d4 d4
Chapter 38. Headaches ....................................................................................................................................... 149
d4 d4
Chapter 39. Heart Failure .................................................................................................................................... 153
d4 d4 d4
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
d4 d4 d4 d4 d4 d4 d4
Chapter 41. Menopausal Hormone Therapy ........................................................................................................ 161
d4 d4 d4 d4
,Chapter 42. Hyperlipidemia................................................................................................................................ 164
d4 d4
Chapter 43. Hypertension ................................................................................................................................... 169
d4 d4
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................. 174
d4 d4 d4 d4
Chapter 45. Obesity ............................................................................................................................................ 177
d4 d4
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
d4 d4 d4 d4 d4 d4 d4
Chapter 47. Pneumonia....................................................................................................................................... 185
d4 d4
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
d4 d4 d4 d4 d4 d4
Chapter 49. Substance Use Disorders .................................................................................................................. 190
d4 d4 d4 d4
Chapter 50. Tuberculosis .................................................................................................................................... 195
d4 d4
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa .................. 197
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
d4 d4 d4 d4
Chapter 53. Women as Patients ........................................................................................................................... 203
d4 d4 d4 d4
Chapter 54. Men as Patients ................................................................................................................................ 207
d4 d4 d4 d4
Chapter 55. Pediatric Patients ............................................................................................................................. 209
d4 d4 d4
Chapter 57. Geriatric Patients ............................................................................................................................. 213
d4 d4 d4
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e 4
d 4
d d4 d4 Ch01
Chapter1.The Role ofthe Advanced PracticeNurse asPrescriber
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
MULTIPLE CHOICE d4
1. Nurse practitioner prescriptive authority is regulated by:
d4 d4 d4 d4 d4 d4
A. The National Council of State Boards ofNursing d4 d4 d4 d4 d4 d4 d4
B. The U.S. Drug Enforcement Administration d4 d4 d4 d4
C. The State Board of Nursing for each state d4 d4 d4 d4 d4 d4 d4
D. The State Board of Pharmacy d4 d4 d4 d4
ANS: d 4 C PTS: d 4 d 4 1
2. Thebenefitstothepatientofhaving anadvanced practice registerednurse(APRN)prescriber
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
d4 include:
A. Nursesknowmoreabout pharmacologythanotherprescribersbecausetheytakeit both
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
in their basic nursing program and in their APRN program.
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
B. Nurses careforthepatientfroma holistic approach and includethepatient in
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
decision-making regarding their care.
d4 d4 d4 d4
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
D. APRNs areabletoprescribeindependentlyinallstates,whereas aphysician’s d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
assistant needs to have a physician supervising their practice.
d4 d4 d4 d4 d4 d4 d4 d4 d4
ANS: d 4 B PTS: d 4 d 4 1
3. Clinical judgment in prescribing includes: d4 d4 d4 d4
A. Factoring in the cost to the patient of the medication prescribed d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
B. Always prescribing the newest medication available for the diseaseprocess d4 d4 d4 d4 d4 d4 d4 d4 d4
C. Handing out drug samples to poor patients d4 d4 d4 d4 d4 d4
D. Prescribing all generic medications to cutcosts d4 d4 d4 d4 d4 d4
ANS: d 4 A PTS: d 4 d 4 1
4. The process for choosing an effective drug for a disorderincludes:
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
A. Asking the patient what drug they think would work best for them d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
B. Consulting nationally recognized guidelines for diseasemanagement d4 d4 d4 d4 d4 d4
C. Prescribingmedications thatare available as samples beforewriting a prescription d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
D. Following U.S. Drug Enforcement Administration guidelines forprescribing d4 d4 d4 d4 d4 d4 d4
ANS: d 4 B PTS: d 4 d 4 1
5. Nonintentional nonadherence of drug therapy may occur due to: d4 d4 d4 d4 d4 d4 d4 d4
A. Belief that medication does not work d4 d4 d4 d4 d4
B. Adverse drug reactions d4 d4
C. Chronic conditions that require dailytherapy d4 d4 d4 d4 d4
D. Forgetfulness ordistraction d4 d4
ANS: d 4 D PTS: d 4 d 4 1
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
d4 d4 d4 d4 d4 d4 d4
Author:Teri Moser Woo and WendyL. Wright
d4 d4 d4 d4 d4 d4 d4
, TABLE OF CONTENT d4 d4
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber............................................................................ 4
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 2. Review of Basic Principles of Pharmacology .......................................................................................... 5
d4 d4 d4 d4 d4 d4 d4
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
d4 d4 d4 d4
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
d4 d4 d4 d4 d4 d4 d4
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
d4 d4 d4 d4
Chapter 6. An Introduction to Pharmacogenomics................................................................................................. 19
d4 d4 d4 d4 d4
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
d4 d4 d4 d4
Chapter 8. Herbal Therapies.................................................................................................................................. 28
d4 d4 d4
Chapter 9. Cannabis.............................................................................................................................................. 31
d4 d4
Chapter 10. Pharmacoeconomics .......................................................................................................................... 35
d4 d4
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
d4 d4 d4 d4 d4 d4 d4
Chapter 12. Drugs Affecting the Central Nervous System...................................................................................... 45
d4 d4 d4 d4 d4 d4 d4
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems...................................................................... 53
d4 d4 d4 d4 d4 d4 d4 d4
Chapter 14. Drugs Affecting the Respiratory System............................................................................................. 61
d4 d4 d4 d4 d4 d4
Chapter 15. Drugs Affecting the Hematological System ........................................................................................ 65
d4 d4 d4 d4 d4 d4
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
d4 d4 d4 d4 d4 d4 d4
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
d4 d4 d4 d4 d4 d4
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormonesand Antidiabetic Drugs .......................... 80
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................... 83
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 21. Drugs Affecting the Reproductive System .......................................................................................... 86
d4 d4 d4 d4 d4 d4
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
d4 d4 d4 d4 d4 d4 d4
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
d4 d4 d4 d4 d4 d4
Chapter 24. Drugs Used to Treat Bacterial Infections ........................................................................................... 101
d4 d4 d4 d4 d4 d4 d4
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections.............................................................. 105
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................... 108
d4 d4 d4 d4 d4 d4 d4
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 28. Anemia ............................................................................................................................................ 113
d4 d4
Chapter 29. Anxiety and Depression ................................................................................................................... 116
d4 d4 d4 d4
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
d4 d4 d4 d4
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
d4 d4 d4 d4
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
d4 d4 d4 d4 d4
Chapter 33. Contraception .................................................................................................................................. 127
d4 d4
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
d4 d4 d4 d4 d4
Chapter 35. Dermatological Conditions .............................................................................................................. 134
d4 d4 d4
Chapter 36. Diabetes Management ..................................................................................................................... 138
d4 d4 d4
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
d4 d4 d4 d4 d4 d4 d4
Chapter 38. Headaches ....................................................................................................................................... 149
d4 d4
Chapter 39. Heart Failure .................................................................................................................................... 153
d4 d4 d4
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
d4 d4 d4 d4 d4 d4 d4
Chapter 41. Menopausal Hormone Therapy ........................................................................................................ 161
d4 d4 d4 d4
,Chapter 42. Hyperlipidemia................................................................................................................................ 164
d4 d4
Chapter 43. Hypertension ................................................................................................................................... 169
d4 d4
Chapter 44. Hyperthyroidism and Hypothyroidism............................................................................................. 174
d4 d4 d4 d4
Chapter 45. Obesity ............................................................................................................................................ 177
d4 d4
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
d4 d4 d4 d4 d4 d4 d4
Chapter 47. Pneumonia....................................................................................................................................... 185
d4 d4
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
d4 d4 d4 d4 d4 d4
Chapter 49. Substance Use Disorders .................................................................................................................. 190
d4 d4 d4 d4
Chapter 50. Tuberculosis .................................................................................................................................... 195
d4 d4
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa .................. 197
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
d4 d4 d4 d4
Chapter 53. Women as Patients ........................................................................................................................... 203
d4 d4 d4 d4
Chapter 54. Men as Patients ................................................................................................................................ 207
d4 d4 d4 d4
Chapter 55. Pediatric Patients ............................................................................................................................. 209
d4 d4 d4
Chapter 57. Geriatric Patients ............................................................................................................................. 213
d4 d4 d4
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e 4
d 4
d d4 d4 Ch01
Chapter1.The Role ofthe Advanced PracticeNurse asPrescriber
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
MULTIPLE CHOICE d4
1. Nurse practitioner prescriptive authority is regulated by:
d4 d4 d4 d4 d4 d4
A. The National Council of State Boards ofNursing d4 d4 d4 d4 d4 d4 d4
B. The U.S. Drug Enforcement Administration d4 d4 d4 d4
C. The State Board of Nursing for each state d4 d4 d4 d4 d4 d4 d4
D. The State Board of Pharmacy d4 d4 d4 d4
ANS: d 4 C PTS: d 4 d 4 1
2. Thebenefitstothepatientofhaving anadvanced practice registerednurse(APRN)prescriber
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
d4 include:
A. Nursesknowmoreabout pharmacologythanotherprescribersbecausetheytakeit both
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
in their basic nursing program and in their APRN program.
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
B. Nurses careforthepatientfroma holistic approach and includethepatient in
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
decision-making regarding their care.
d4 d4 d4 d4
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
D. APRNs areabletoprescribeindependentlyinallstates,whereas aphysician’s d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
assistant needs to have a physician supervising their practice.
d4 d4 d4 d4 d4 d4 d4 d4 d4
ANS: d 4 B PTS: d 4 d 4 1
3. Clinical judgment in prescribing includes: d4 d4 d4 d4
A. Factoring in the cost to the patient of the medication prescribed d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
B. Always prescribing the newest medication available for the diseaseprocess d4 d4 d4 d4 d4 d4 d4 d4 d4
C. Handing out drug samples to poor patients d4 d4 d4 d4 d4 d4
D. Prescribing all generic medications to cutcosts d4 d4 d4 d4 d4 d4
ANS: d 4 A PTS: d 4 d 4 1
4. The process for choosing an effective drug for a disorderincludes:
d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
A. Asking the patient what drug they think would work best for them d4 d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
B. Consulting nationally recognized guidelines for diseasemanagement d4 d4 d4 d4 d4 d4
C. Prescribingmedications thatare available as samples beforewriting a prescription d4 d4 d4 d4 d4 d4 d4 d4 d4 d4
D. Following U.S. Drug Enforcement Administration guidelines forprescribing d4 d4 d4 d4 d4 d4 d4
ANS: d 4 B PTS: d 4 d 4 1
5. Nonintentional nonadherence of drug therapy may occur due to: d4 d4 d4 d4 d4 d4 d4 d4
A. Belief that medication does not work d4 d4 d4 d4 d4
B. Adverse drug reactions d4 d4
C. Chronic conditions that require dailytherapy d4 d4 d4 d4 d4
D. Forgetfulness ordistraction d4 d4
ANS: d 4 D PTS: d 4 d 4 1
